Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens

The paper gives the results of the largest international studies demonstrating the efficacy and safety of Raltegravir as part of antiretroviral treatment (ARVT) regimens in both patients starting therapy (STARTMRK study) and those pretreated with antiretroviral drugs (BENCHMRK study). The advantage...

Description complète

Détails bibliographiques

Auteurs principaux:	Aleksey Viktorovich Kravchenko, A V Kravchenko
Format:	Artigo
Langue:	Russo
Publié:	"Consilium Medicum" Publishing house 2010-11-01
Collection:	Терапевтический архив
Sujets:	hiv infection antiretroviral therapy the hiv integrase inhibitor raltegravir
Accès en ligne:	https://ter-arkhiv.ru/0040-3660/article/view/30714
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!